Similar articles

• Prophylactic endoscopic sclerotherapy in patients with liver cirrhosis, portal hypertension, and esophageal varices.

  Paquet KJ, Kuhn R. Paquet KJ, et al. Hepatogastroenterology. 1997 May-Jun;44(15):625-36. Hepatogastroenterology. 1997. PMID: 9222663 Review.
• [Combined use of peritoneo-atrial shunting and endoscopic sclerotherapy of esophageal varicose veins in treating liver cirrhosis with portal hypertension and resistant ascites].

  Vakhidov AV, Nazyrov FG, Strusskiĭ LP, Akilov KhA, Deviatov AV, Asabaev ASh. Vakhidov AV, et al. Klin Khir (1962). 1990;(9):3-5. Klin Khir (1962). 1990. PMID: 2273775 Russian.
• Efficacy of endoscopic sclerotherapy on long-term management of oesophageal varices due to cirrhosis of liver, non-cirrhotic portal fibrosis and extrahepatic obstruction: comparison of results.

  Bhargava DK, Dasarathy S, Sundaram KR, Ahuja RK. Bhargava DK, et al. J Gastroenterol Hepatol. 1989;4 Suppl 1:198-200. J Gastroenterol Hepatol. 1989. PMID: 2519051 No abstract available.
• [Therapeutic strategies for portal hypertension of liver cirrhosis with esophageal and gastric varicose].

  Zhu YQ, Zhang PY. Zhu YQ, et al. Zhonghua Gan Zang Bing Za Zhi. 2004 Aug;12(8):507-9. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15329224 Review. Chinese. No abstract available.
• [Pharmacologic treatment or endoscopic sclerotherapy as primary intervention for bleeding varices in cirrhotic patients].

  Grønbaek H, Dahlerup JF, Vilstrup H. Grønbaek H, et al. Ugeskr Laeger. 2003 Mar 10;165(11):1127-30. Ugeskr Laeger. 2003. PMID: 12677989 Danish. No abstract available.